Literature DB >> 23934397

Hyperspectral unmixing of Raman micro-images for assessment of morphological and chemical parameters in non-dried brain tumor specimens.

Norbert Bergner1, Anna Medyukhina, Kathrin D Geiger, Matthias Kirsch, Gabriele Schackert, Christoph Krafft, Jürgen Popp.   

Abstract

Hyperspectral unmixing is an unsupervised algorithm to calculate a bilinear model of spectral endmembers and abundances of components from Raman images. Thirty-nine Raman images were collected from six glioma brain tumor specimens. The tumor grades ranged from astrocytoma WHO II to glioblastoma multiforme WHO IV. The abundance plots of the cell nuclei were processed by an image segmentation procedure to determine the average nuclei size, the number of nuclei, and the fraction of nuclei area. The latter two morphological parameters correlated with the malignancy. A combination of spectral unmixing and non-negativity constrained linear least squares fitting is introduced to assess chemical parameters. First, endmembers of the most abundant and most dissimilar components were defined that represent all data sets. Second, the content of the obtained components' proteins, nucleic acids, lipids, and lipid to protein ratios were determined in all Raman images. Except for the protein content, all chemical parameters correlated with the malignancy. We conclude that the morphological and chemical information offer new ways to develop Raman-based classification approaches that can complement diagnosis of brain tumors. The role of non-linear Raman modalities to speed-up image acquisition is discussed.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23934397     DOI: 10.1007/s00216-013-7257-7

Source DB:  PubMed          Journal:  Anal Bioanal Chem        ISSN: 1618-2642            Impact factor:   4.142


  8 in total

1.  Raman active components of skin cancer.

Authors:  Xu Feng; Austin J Moy; Hieu T M Nguyen; Jason Zhang; Matthew C Fox; Katherine R Sebastian; Jason S Reichenberg; Mia K Markey; James W Tunnell
Journal:  Biomed Opt Express       Date:  2017-05-04       Impact factor: 3.732

Review 2.  Improving the accuracy of brain tumor surgery via Raman-based technology.

Authors:  Todd Hollon; Spencer Lewis; Christian W Freudiger; X Sunney Xie; Daniel A Orringer
Journal:  Neurosurg Focus       Date:  2016-03       Impact factor: 4.047

3.  Rise of Raman spectroscopy in neurosurgery: a review.

Authors:  Damon DePaoli; Émile Lemoine; Katherine Ember; Martin Parent; Michel Prud'homme; Léo Cantin; Kevin Petrecca; Frédéric Leblond; Daniel C Côté
Journal:  J Biomed Opt       Date:  2020-05       Impact factor: 3.170

4.  IDH1 mutation in human glioma induces chemical alterations that are amenable to optical Raman spectroscopy.

Authors:  Ortrud Uckermann; Wenmin Yao; Tareq A Juratli; Roberta Galli; Elke Leipnitz; Matthias Meinhardt; Edmund Koch; Gabriele Schackert; Gerald Steiner; Matthias Kirsch
Journal:  J Neurooncol       Date:  2018-05-14       Impact factor: 4.130

5.  Quantitative volumetric Raman imaging of three dimensional cell cultures.

Authors:  Charalambos Kallepitis; Mads S Bergholt; Manuel M Mazo; Vincent Leonardo; Stacey C Skaalure; Stephanie A Maynard; Molly M Stevens
Journal:  Nat Commun       Date:  2017-03-22       Impact factor: 14.919

Review 6.  Hyperspectral imaging solutions for brain tissue metabolic and hemodynamic monitoring: past, current and future developments.

Authors:  Luca Giannoni; Frédéric Lange; Ilias Tachtsidis
Journal:  J Opt       Date:  2018-03-22       Impact factor: 2.516

7.  In vivo measurement of cytoplasmic organelle water fraction using diffusion-weighted imaging: Application in the malignant grading and differential diagnosis of gliomas.

Authors:  Chenhan Ling; Feina Shi; Jianmin Zhang; Biao Jiang; Fei Dong; Qiang Zeng
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

8.  Rapid Label-Free Analysis of Brain Tumor Biopsies by Near Infrared Raman and Fluorescence Spectroscopy-A Study of 209 Patients.

Authors:  Roberta Galli; Matthias Meinhardt; Edmund Koch; Gabriele Schackert; Gerald Steiner; Matthias Kirsch; Ortrud Uckermann
Journal:  Front Oncol       Date:  2019-11-05       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.